Quality of Life and Patients Satisfaction

  • José Luis FougoEmail author


Although not scientifically proven yet, there are patient-driven data that suggest that TIVADs have brought gains to the quality of life of oncologic patients.


Quality of life Morbidity Outpatient 


  1. 1.
    Niederhuber JE, Ensminger W, Gyves JW et al (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMedGoogle Scholar
  2. 2.
    Bow EJ, Kilpatrick MG, Clinch JJ (1999) Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs and impact on quality of life. J Clin Oncol 17:1267–1273PubMedGoogle Scholar
  3. 3.
    Teichgraber UK, Kausche S, Nagel SN, Gebauer B (2011) Outcome analysis in 3160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol 2011 DOI: [Epub ahead of print] doi:10.1007/s00330-010-2045-7Google Scholar
  4. 4.
    Kreis H, Loheberg CR, Lux MP et al (2007) Patient’s attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur J Surg Oncol 33:39–43PubMedCrossRefGoogle Scholar
  5. 5.
    Vescia S, Baumgartner AK, Jacobs VR et al (2008) Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19:9–15PubMedCrossRefGoogle Scholar
  6. 6.
    Araújo C, Silva JP, Antunes P et al (2008) A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. Eur J Surg Oncol 34:222–226PubMedCrossRefGoogle Scholar
  7. 7.
    Fougo JL (2008) Cateteres venosos centrais de longa duração: considerações práticas sobre a sua colocação, utilização e remoção. Lidel-edições técnicas, Lda, PortugalGoogle Scholar
  8. 8.
    Di Carlo I, Pulvirenti E, Mannino M, Toro A (2010) Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. Ann Surg Oncol 17:1649–1656PubMedCrossRefGoogle Scholar
  9. 9.
    Teichgraber UK, Pfitzman R, Hofmann HA (2011) Central venous port systems as an integral part of chemotherapy. Dtsch Arztbl Int 108:147–154Google Scholar
  10. 10.
    Biffi R, Orsi F, Pozzi S et al (2010) No impact of central venous insertion site on oncology patients’ quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer 2010 DOI: [Epub ahead of print] doi:10.1007/s00520-010-0984-9Google Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  1. 1.Breast Centre and Department of General SurgeryHospital de São JoãoPortoPortugal

Personalised recommendations